Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 211

1.

Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial. CHART Steering committee.

Saunders M, Dische S, Barrett A, Harvey A, Griffiths G, Palmar M.

Radiother Oncol. 1999 Aug;52(2):137-48.

PMID:
10577699
[PubMed - indexed for MEDLINE]
2.

Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial. CHART Steering Committee.

Saunders M, Dische S, Barrett A, Harvey A, Gibson D, Parmar M.

Lancet. 1997 Jul 19;350(9072):161-5.

PMID:
9250182
[PubMed - indexed for MEDLINE]
3.

Randomised multicentre trials of CHART vs conventional radiotherapy in head and neck and non-small-cell lung cancer: an interim report. CHART Steering Committee.

Saunders MI, Dische S, Barrett A, Parmar MK, Harvey A, Gibson D.

Br J Cancer. 1996 Jun;73(12):1455-62.

PMID:
8664112
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer.

Dische S, Saunders M, Barrett A, Harvey A, Gibson D, Parmar M.

Radiother Oncol. 1997 Aug;44(2):123-36.

PMID:
9288840
[PubMed - indexed for MEDLINE]
5.

Experience with dose escalation using CHARTWEL (continuous hyperfractionated accelerated radiotherapy weekend less) in non-small-cell lung cancer.

Saunders MI, Rojas A, Lyn BE, Pigott K, Powell M, Goodchild K, Hoskin PJ, Phillips H, Verma N.

Br J Cancer. 1998 Nov;78(10):1323-8.

PMID:
9823973
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Dose, volume, and tumor control prediction in primary radiotherapy of non-small-cell lung cancer.

Willner J, Baier K, Caragiani E, Tschammler A, Flentje M.

Int J Radiat Oncol Biol Phys. 2002 Feb 1;52(2):382-9.

PMID:
11872283
[PubMed - indexed for MEDLINE]
7.

Postoperative radiotherapy in radically resected non-small cell lung cancer.

Mayer R, Smolle-Juettner FM, Szolar D, Stuecklschweiger GF, Quehenberger F, Friehs G, Hackl A.

Chest. 1997 Oct;112(4):954-9. Erratum in: Chest 1998 Feb;113(2):564.

PMID:
9377958
[PubMed - indexed for MEDLINE]
8.

[Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].

Cai Y, Wang WL, Xu B, Zhu GY, Zhang SW.

Ai Zheng. 2006 Nov;25(11):1419-22. Chinese.

PMID:
17094913
[PubMed - indexed for MEDLINE]
9.

A systematic overview of radiation therapy effects in non-small cell lung cancer.

Sirzén F, Kjellén E, Sörenson S, Cavallin-Ståhl E.

Acta Oncol. 2003;42(5-6):493-515. Review.

PMID:
14596509
[PubMed - indexed for MEDLINE]
10.

Hypofractionated palliative radiotherapy (17 Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: a national phase III trial.

Sundstrøm S, Bremnes R, Aasebø U, Aamdal S, Hatlevoll R, Brunsvig P, Johannessen DC, Klepp O, Fayers PM, Kaasa S.

J Clin Oncol. 2004 Mar 1;22(5):801-10.

PMID:
14990635
[PubMed - indexed for MEDLINE]
Free Article
11.

Escalated hyperfractionated accelerated radiation therapy for locally advanced non-small cell lung cancer: a clinical phase II trial.

Chen GY, Jiang GL, Qian H, Wang LJ, Yang HJ, Fu XL, Wu KL, Zang Z, Zhao S.

Radiother Oncol. 2004 May;71(2):157-62.

PMID:
15110448
[PubMed - indexed for MEDLINE]
12.

Final results of the randomized phase III CHARTWEL-trial (ARO 97-1) comparing hyperfractionated-accelerated versus conventionally fractionated radiotherapy in non-small cell lung cancer (NSCLC).

Baumann M, Herrmann T, Koch R, Matthiessen W, Appold S, Wahlers B, Kepka L, Marschke G, Feltl D, Fietkau R, Budach V, Dunst J, Dziadziuszko R, Krause M, Zips D; CHARTWEL-Bronchus studygroup.

Radiother Oncol. 2011 Jul;100(1):76-85. doi: 10.1016/j.radonc.2011.06.031. Epub 2011 Jul 13.

PMID:
21757247
[PubMed - indexed for MEDLINE]
13.

Radiation therapy of stage I and II non-small cell lung cancer (NSCLC).

Zierhut D, Bettscheider C, Schubert K, van Kampen M, Wannenmacher M.

Lung Cancer. 2001 Dec;34 Suppl 3:S39-43.

PMID:
11740992
[PubMed - indexed for MEDLINE]
14.

HI-CHART: a phase I/II study on the feasibility of high-dose continuous hyperfractionated accelerated radiotherapy in patients with inoperable non-small-cell lung cancer.

De Ruysscher D, Wanders R, van Haren E, Hochstenbag M, Geraedts W, Pitz C, Simons J, Boersma L, Verschueren T, Minken A, Bentzen SM, Lambin P.

Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):132-8. Epub 2007 Nov 26.

PMID:
18037581
[PubMed - indexed for MEDLINE]
15.

Randomized phase I study of standard-fractionated or accelerated-hyperfractionated radiotherapy with concurrent cisplatin and vindesine for unresectable non-small cell lung cancer: a report of Japan Clinical Oncology Group Study (JCOG 9601).

Tsuchiya S, Ohe Y, Sugiura T, Fuwa N, Kitamoto Y, Mori K, Kobayashi H, Nakata K, Sawa T, Hirai K, Etoh T, Saka H, Saito A, Fukuda H, Ishizuka N, Saijo N; Japan Clinical Oncology Group Study.

Jpn J Clin Oncol. 2001 Oct;31(10):488-94.

PMID:
11696618
[PubMed - indexed for MEDLINE]
Free Article
16.

A randomised phase III study of accelerated or standard fraction radiotherapy with or without concurrent carboplatin in inoperable non-small cell lung cancer: final report of an Australian multi-centre trial.

Ball D, Bishop J, Smith J, O'Brien P, Davis S, Ryan G, Olver I, Toner G, Walker Q, Joseph D.

Radiother Oncol. 1999 Aug;52(2):129-36.

PMID:
10577698
[PubMed - indexed for MEDLINE]
17.

Hyperfractionated accelerated radiotherapy (HART) for inoperable, nonmetastatic non-small cell lung carcinoma of the lung (NSCLC): results of a phase II study for patients ineligible for combination radiochemotherapy.

Koutaïssoff S, Wellmann D, Coucke P, Ozsahin M, Pampallona S, Mirimanoff RO.

Int J Radiat Oncol Biol Phys. 1999 Dec 1;45(5):1151-6.

PMID:
10613307
[PubMed - indexed for MEDLINE]
18.

Quality of life assessment in advanced non-small-cell lung cancer patients undergoing an accelerated radiotherapy regimen: report of ECOG study 4593. Eastern Cooperative Oncology Group.

Auchter RM, Scholtens D, Adak S, Wagner H, Cella DF, Mehta MP.

Int J Radiat Oncol Biol Phys. 2001 Aug 1;50(5):1199-206.

PMID:
11483329
[PubMed - indexed for MEDLINE]
20.

Palliative thoracic radiotherapy in locally advanced non-small cell lung cancer: can quality-of-life assessments help in selection of patients for short- or long-course radiotherapy?

Sundstrøm S, Bremnes RM, Brunsvig P, Aasebø U, Kaasa S; Norwegian Lung Cancer Study Group.

J Thorac Oncol. 2006 Oct;1(8):816-24.

PMID:
17409965
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk